Peptides 1994-01-01

The effects of PACAP and VIP on guinea pig tracheal smooth muscle in vitro.

R Bhogal, R L Sheldrick, R A Coleman, D M Smith, S R Bloom

Index: Peptides 15(7) , 1237-41, (1994)

Full Text: HTML

Abstract

Neither pituitary adenylate cyclase activating polypeptide-38 (PACAP) nor its homologue, vasoactive intestinal polypeptide (VIP), contracted guinea pig isolated trachea (GPT), but on preparations contracted with KCl (40 mM), both caused concentration-related relaxation (3 nM-3 microM, VIP IC50 = 72 nM, PACAP IC50 = 224 nM). Relaxant curves to PACAP were slower in reaching a maximum than those to VIP (approximately 150 and 50 min, respectively). The protease inhibitors, phosphoramidon (1 microM), leupeptin (50 microM), bestatin (100 microM), soya bean trypsin inhibitor (1 microM), and aprotinin (5 microM), together caused a small enhancement of relaxations to VIP, but not to PACAP. The VIP antagonist, [4-Cl-D-Phe6, Leu17]VIP (1-10 microM), did not inhibit the relaxation to either peptide, but did cause large contractions, which were enhanced by protease inhibition. These findings demonstrate that PACAP relaxes GPT in a similar manner to VIP.


Related Compounds

Related Articles:

Vasoactive intestinal polypeptide antagonists attenuate vagally induced tachycardia in the anesthetized dog.

1995-10-01

[Am. J. Physiol. 269(4 Pt 2) , H1467-72, (1995)]

Pituitary adenylate cyclase-activating peptide stimulates cyclic AMP accumulation in UMR 106 osteoblast-like cells.

1996-05-01

[J. Endocrinol. 149 , 287, (1996)]

Vagal nerve stimulation increases right ventricular contraction and relaxation and heart rate.

1996-11-01

[Cardiovasc. Res. 32(5) , 846-53, (1996)]

Homeostatic and therapeutic roles of VIP in smooth muscle function: myo-neuroimmune interactions.

2009-10-01

[Am. J. Physiol. Gastrointest. Liver Physiol. 297(4) , G716-25, (2009)]

Enhancement by atropine of the pancreatic exocrine secretions evoked by vagal stimulation in the pithed rat.

1993-09-01

[J. Physiol. 469 , 443-57, (1993)]

More Articles...